Published in Proc Natl Acad Sci U S A on April 22, 2013
Force transmission during adhesion-independent migration. Nat Cell Biol (2015) 1.19
Macroscopic stiffness of breast tumors predicts metastasis. Sci Rep (2014) 1.04
Measuring single cell mass, volume, and density with dual suspended microchannel resonators. Lab Chip (2014) 1.01
Microconstriction arrays for high-throughput quantitative measurements of cell mechanical properties. Biophys J (2015) 1.00
A microfluidic pipette array for mechanophenotyping of cancer cells and mechanical gating of mechanosensitive channels. Lab Chip (2015) 1.00
Advances in high-throughput single-cell microtechnologies. Curr Opin Biotechnol (2013) 0.95
Extracting Cell Stiffness from Real-Time Deformability Cytometry: Theory and Experiment. Biophys J (2015) 0.91
Neural regulation of cancer: from mechanobiology to inflammation. Clin Transl Immunology (2016) 0.90
Deformability of Tumor Cells versus Blood Cells. Sci Rep (2015) 0.88
Nuclear mechanics in cancer. Adv Exp Med Biol (2014) 0.88
Physical biology in cancer. 2. The physical biology of circulating tumor cells. Am J Physiol Cell Physiol (2013) 0.87
Clusters of circulating tumor cells traverse capillary-sized vessels. Proc Natl Acad Sci U S A (2016) 0.86
Screening cell mechanotype by parallel microfiltration. Sci Rep (2015) 0.84
Microfluidic impedance flow cytometry enabling high-throughput single-cell electrical property characterization. Int J Mol Sci (2015) 0.84
Single Cell Electrical Characterization Techniques. Int J Mol Sci (2015) 0.83
Impact of dimensionality and network disruption on microrheology of cancer cells in 3D environments. PLoS Comput Biol (2014) 0.82
Bioengineering paradigms for cell migration in confined microenvironments. Curr Opin Cell Biol (2014) 0.82
Towards the Biological Understanding of CTC: Capture Technologies, Definitions and Potential to Create Metastasis. Cancers (Basel) (2013) 0.82
Benchtop technologies for circulating tumor cells separation based on biophysical properties. Biomed Res Int (2015) 0.80
Recent progress on lipid lateral heterogeneity in plasma membranes: From rafts to submicrometric domains. Prog Lipid Res (2015) 0.80
Shape in migration: quantitative image analysis of migrating chemoresistant HCT-8 colon cancer cells. Cell Adh Migr (2013) 0.80
Decreased deformability of lymphocytes in chronic lymphocytic leukemia. Sci Rep (2015) 0.79
On-chip actuation transmitter for enhancing the dynamic response of cell manipulation using a macro-scale pump. Biomicrofluidics (2015) 0.79
Characterizing Cellular Biophysical Responses to Stress by Relating Density, Deformability, and Size. Biophys J (2015) 0.78
Entry effects of droplet in a micro confinement: Implications for deformation-based circulating tumor cell microfiltration. Biomicrofluidics (2015) 0.78
Microfluidic cytometric analysis of cancer cell transportability and invasiveness. Sci Rep (2015) 0.78
Pulled microcapillary tube resonators with electrical readout for mass sensing applications. Sci Rep (2016) 0.78
A microfluidic technique to probe cell deformability. J Vis Exp (2014) 0.76
The Potential for Circulating Tumor Cells in Pancreatic Cancer Management. Front Physiol (2017) 0.76
Tumour-suppressor microRNAs regulate ovarian cancer cell physical properties and invasive behaviour. Open Biol (2016) 0.75
Cancer cells become less deformable and more invasive with activation of β-adrenergic signaling. J Cell Sci (2016) 0.75
Effects of methotrexate on the viscoelastic properties of single cells probed by atomic force microscopy. J Biol Phys (2016) 0.75
Recent Progress of Microfluidics in Translational Applications. Adv Healthc Mater (2016) 0.75
Unbiased High-Precision Cell Mechanical Measurements with Microconstrictions. Biophys J (2017) 0.75
Biophysical changes reduce energetic demand in growth factor-deprived lymphocytes. J Cell Biol (2016) 0.75
Multiparameter mechanical and morphometric screening of cells. Sci Rep (2016) 0.75
Sciellin mediates mesenchymal-to-epithelial transition in colorectal cancer hepatic metastasis. Oncotarget (2016) 0.75
Deformability-based cell selection with downstream immunofluorescence analysis. Integr Biol (Camb) (2016) 0.75
Self-sustained lift and low friction via soft lubrication. Proc Natl Acad Sci U S A (2016) 0.75
Forces, Flows, Fluorescence, and μFluidics. Biophys J (2017) 0.75
Microfluidic Cell Deformability Assay for Rapid and Efficient Kinase Screening with the CRISPR-Cas9 System. Angew Chem Int Ed Engl (2016) 0.75
Microfluidic cell fragmentation for mechanical phenotyping of cancer cells. Biomicrofluidics (2016) 0.75
Microfluidic Iterative Mechanical Characteristics (iMECH) Analyzer for Single-Cell Metastatic Identification. Anal Methods (2017) 0.75
Biophysical isolation and identification of circulating tumor cells. Lab Chip (2017) 0.75
Use of Shear Wave Ultrasound Vibrometry for Detection of Simulated Esophageal Malignancy in Ex Vivo Porcine Esophagi. Biomed Phys Eng Express (2016) 0.75
Quantitative Deformability Cytometry: Rapid, Calibrated Measurements of Cell Mechanical Properties. Biophys J (2017) 0.75
High-throughput cell mechanical phenotyping for label-free titration assays of cytoskeletal modifications. Cytoskeleton (Hoboken) (2017) 0.75
Microcantilevers track single-cell mass. Nat Biotechnol (2016) 0.75
Sorting cells by their density. PLoS One (2017) 0.75
Evaluation of the metastatic potential of malignant cells by image processing of digital holographic microscopy data. FEBS Open Bio (2017) 0.75
Single-Cell Mechanical Characteristics Analyzed by Multiconstriction Microfluidic Channels. ACS Sens (2017) 0.75
The basics of epithelial-mesenchymal transition. J Clin Invest (2009) 32.82
Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature (2007) 19.33
Mechanotransduction across the cell surface and through the cytoskeleton. Science (1993) 14.01
Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc Natl Acad Sci U S A (2010) 7.77
Weighing of biomolecules, single cells and single nanoparticles in fluid. Nature (2007) 6.42
Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients. Clin Cancer Res (2005) 4.94
Biomolecular imaging with the atomic force microscope. Annu Rev Biophys Biomol Struct (1994) 4.89
Micropipette aspiration of living cells. J Biomech (2000) 4.40
Local measurements of viscoelastic parameters of adherent cell surfaces by magnetic bead microrheometry. Biophys J (1998) 4.36
Mechanics, malignancy, and metastasis: the force journey of a tumor cell. Cancer Metastasis Rev (2009) 4.36
Mechanics of living cells measured by laser tracking microrheology. Biophys J (2000) 3.56
The physics of cancer: the role of physical interactions and mechanical forces in metastasis. Nat Rev Cancer (2011) 3.42
Suppression of lung adenocarcinoma progression by Nkx2-1. Nature (2011) 3.27
The optical stretcher: a novel laser tool to micromanipulate cells. Biophys J (2001) 3.14
Mass and position determination of attached particles on cantilever based mass sensors. Rev Sci Instrum (2007) 2.76
Micromechanical mapping of live cells by multiple-particle-tracking microrheology. Biophys J (2002) 2.63
Nuclear lamin A/C deficiency induces defects in cell mechanics, polarization, and migration. Biophys J (2007) 2.51
Hydrodynamic stretching of single cells for large population mechanical phenotyping. Proc Natl Acad Sci U S A (2012) 2.37
Direct observation of mammalian cell growth and size regulation. Nat Methods (2012) 2.34
Mechanical stiffness grades metastatic potential in patient tumor cells and in cancer cell lines. Cancer Res (2011) 2.32
Mechanical models for living cells--a review. J Biomech (2006) 2.26
Cell stiffness is a biomarker of the metastatic potential of ovarian cancer cells. PLoS One (2012) 2.23
Deformability-based cell classification and enrichment using inertial microfluidics. Lab Chip (2011) 2.21
Optimization of an enrichment process for circulating tumor cells from the blood of head and neck cancer patients through depletion of normal cells. Biotechnol Bioeng (2009) 2.16
Measurement of mass, density, and volume during the cell cycle of yeast. Proc Natl Acad Sci U S A (2009) 2.04
Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell lines. Science (1981) 1.88
Analyzing cell mechanics in hematologic diseases with microfluidic biophysical flow cytometry. Lab Chip (2008) 1.82
Passive mechanical behavior of human neutrophils: power-law fluid. Biophys J (1993) 1.71
Measuring the elastic properties of living cells by the atomic force microscope. Methods Cell Biol (2002) 1.62
Deformability study of breast cancer cells using microfluidics. Biomed Microdevices (2009) 1.36
High-throughput biophysical measurement of human red blood cells. Lab Chip (2012) 1.34
Aspiration of human neutrophils: effects of shear thinning and cortical dissipation. Biophys J (2001) 1.25
DNA methylation profiling defines clinically relevant biological subsets of non-small cell lung cancer. Clin Cancer Res (2012) 1.16
Classification of cell types using a microfluidic device for mechanical and electrical measurement on single cells. Lab Chip (2011) 1.15
Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patients. J Transl Med (2011) 1.15
Microfluidics-based assessment of cell deformability. Anal Chem (2012) 1.13
Microfluidic investigation reveals distinct roles for actin cytoskeleton and myosin II activity in capillary leukocyte trafficking. Biophys J (2009) 1.11
Neutrophil transit times through pulmonary capillaries: the effects of capillary geometry and fMLP-stimulation. Biophys J (2002) 1.01
A simple microfluidic method to select, isolate, and manipulate single-cells in mechanical and biochemical assays. Lab Chip (2010) 0.95
Kinetics of granulocyte deformability following exposure to chemotactic stimuli. Blood Cells (1992) 0.91
MicroRNA expression profiles classify human cancers. Nature (2005) 69.12
Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature (2009) 35.48
Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet (2007) 15.46
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell (2003) 15.43
Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell (2005) 15.06
Restoration of p53 function leads to tumour regression in vivo. Nature (2007) 12.62
Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell (2008) 12.29
A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell (2010) 12.27
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature (2009) 11.46
An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis. Nat Genet (2004) 10.92
ProteoWizard: open source software for rapid proteomics tools development. Bioinformatics (2008) 9.47
Cre-lox-regulated conditional RNA interference from transgenes. Proc Natl Acad Sci U S A (2004) 9.33
Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome. Cell (2004) 8.48
Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. Cancer Cell (2004) 8.16
The PeptideAtlas project. Nucleic Acids Res (2006) 7.87
MicroRNAs and cancer: short RNAs go a long way. Cell (2009) 7.25
Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc Natl Acad Sci U S A (2008) 6.89
Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells. Cell (2009) 6.55
Weighing of biomolecules, single cells and single nanoparticles in fluid. Nature (2007) 6.42
Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry. Nature (2003) 6.01
The differential effects of mutant p53 alleles on advanced murine lung cancer. Cancer Res (2005) 5.93
An essential switch in subunit composition of a chromatin remodeling complex during neural development. Neuron (2007) 5.35
Dicer1 functions as a haploinsufficient tumor suppressor. Genes Dev (2009) 5.21
Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon. Nat Genet (2008) 5.07
Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer. Nat Med (2004) 4.98
Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma. Nature (2009) 4.93
Integration with the human genome of peptide sequences obtained by high-throughput mass spectrometry. Genome Biol (2004) 4.91
NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Nature (2006) 4.80
AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer. Cancer Cell (2009) 4.71
Scoring proteomes with proteotypic peptide probes. Nat Rev Mol Cell Biol (2005) 4.63
p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature (2002) 4.56
Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase. Nat Protoc (2009) 4.50
A cross-platform toolkit for mass spectrometry and proteomics. Nat Biotechnol (2012) 4.48
Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family. Cancer Cell (2005) 4.14
A spatially and temporally restricted mouse model of soft tissue sarcoma. Nat Med (2007) 3.96
Expression of tumour-specific antigens underlies cancer immunoediting. Nature (2012) 3.89
Recommendations from the 2008 International Summit on Proteomics Data Release and Sharing Policy: the Amsterdam principles. J Proteome Res (2009) 3.77
Growth-inhibitory and tumor- suppressive functions of p53 depend on its repression of CD44 expression. Cell (2008) 3.75
Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease. J Clin Invest (2004) 3.47
Classification of proliferative pulmonary lesions of the mouse: recommendations of the mouse models of human cancers consortium. Cancer Res (2004) 3.43
A high-confidence human plasma proteome reference set with estimated concentrations in PeptideAtlas. Mol Cell Proteomics (2011) 3.37
Context-dependent transformation of adult pancreatic cells by oncogenic K-Ras. Cancer Cell (2009) 3.37
Treating metastatic cancer with nanotechnology. Nat Rev Cancer (2011) 3.30
Suppression of lung adenocarcinoma progression by Nkx2-1. Nature (2011) 3.27
Cancer modeling in the modern era: progress and challenges. Cell (2002) 3.12
Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1. Nature (2002) 3.05
Stage-specific sensitivity to p53 restoration during lung cancer progression. Nature (2010) 3.03
Calcineurin/NFAT signalling regulates pancreatic beta-cell growth and function. Nature (2006) 2.96
Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis. Genes Dev (2013) 2.90
Making it stick: convection, reaction and diffusion in surface-based biosensors. Nat Biotechnol (2008) 2.82
The standard protein mix database: a diverse data set to assist in the production of improved Peptide and protein identification software tools. J Proteome Res (2007) 2.77
Single-molecule transcript counting of stem-cell markers in the mouse intestine. Nat Cell Biol (2011) 2.72
Using buoyant mass to measure the growth of single cells. Nat Methods (2010) 2.67
PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells. Cell (2013) 2.38
Direct observation of mammalian cell growth and size regulation. Nat Methods (2012) 2.34
Nuclear factor I/B is an oncogene in small cell lung cancer. Genes Dev (2011) 2.29
Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function. Proc Natl Acad Sci U S A (2002) 2.24
Merlin, the product of the Nf2 tumor suppressor gene, is an inhibitor of the p21-activated kinase, Pak1. Mol Cell (2003) 2.23
Calcineurin B1 is essential for positive but not negative selection during thymocyte development. Immunity (2004) 2.20
Cell type-specific effects of Rb deletion in the murine retina. Genes Dev (2004) 2.18
p53 controls radiation-induced gastrointestinal syndrome in mice independent of apoptosis. Science (2009) 2.11
Nkx2-1 represses a latent gastric differentiation program in lung adenocarcinoma. Mol Cell (2013) 2.05
Inference of protein function and protein linkages in Mycobacterium tuberculosis based on prokaryotic genome organization: a combined computational approach. Genome Biol (2003) 2.04
Proliferation and tumorigenesis of a murine sarcoma cell line in the absence of DICER1. Cancer Cell (2012) 2.04
Measurement of mass, density, and volume during the cell cycle of yeast. Proc Natl Acad Sci U S A (2009) 2.04
Electronic detection of DNA by its intrinsic molecular charge. Proc Natl Acad Sci U S A (2002) 2.01
Suppression of Rev3, the catalytic subunit of Pol{zeta}, sensitizes drug-resistant lung tumors to chemotherapy. Proc Natl Acad Sci U S A (2010) 1.95
Chronic cisplatin treatment promotes enhanced damage repair and tumor progression in a mouse model of lung cancer. Genes Dev (2010) 1.95
High throughput quantitative analysis of serum proteins using glycopeptide capture and liquid chromatography mass spectrometry. Mol Cell Proteomics (2004) 1.94
Use of gene expression profiling to direct in vivo molecular imaging of lung cancer. Proc Natl Acad Sci U S A (2005) 1.91
Measuring single-cell density. Proc Natl Acad Sci U S A (2011) 1.91
Endogenous T cell responses to antigens expressed in lung adenocarcinomas delay malignant tumor progression. Cancer Cell (2011) 1.89
HIF-2alpha deletion promotes Kras-driven lung tumor development. Proc Natl Acad Sci U S A (2010) 1.86
The related retinoblastoma (pRb) and p130 proteins cooperate to regulate homeostasis in the intestinal epithelium. J Biol Chem (2005) 1.85
Merlin phosphorylation by p21-activated kinase 2 and effects of phosphorylation on merlin localization. J Biol Chem (2002) 1.82
GXXXG and AXXXA: common alpha-helical interaction motifs in proteins, particularly in extremophiles. Biochemistry (2002) 1.82
Protein cross-linking analysis using mass spectrometry, isotope-coded cross-linkers, and integrated computational data processing. J Proteome Res (2006) 1.81
Sprouty-2 regulates oncogenic K-ras in lung development and tumorigenesis. Genes Dev (2007) 1.81
ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-2/phosphatidylinositol 3-kinase/mammalian target of rapamycin signaling axis to form glioblastoma in mice. Cancer Res (2006) 1.80
Requirement for Rac1 in a K-ras induced lung cancer in the mouse. Cancer Res (2007) 1.80
A functional switch from lung cancer resistance to susceptibility at the Pas1 locus in Kras2LA2 mice. Nat Genet (2006) 1.79
Chimeric mouse tumor models reveal differences in pathway activation between ERBB family- and KRAS-dependent lung adenocarcinomas. Nat Biotechnol (2009) 1.76
Progesterone receptor expression in neurofibromas. Cancer Res (2003) 1.72
Mist1-KrasG12D knock-in mice develop mixed differentiation metastatic exocrine pancreatic carcinoma and hepatocellular carcinoma. Cancer Res (2006) 1.69
Targeted deletion reveals an essential function for the telomere length regulator Trf1. Mol Cell Biol (2003) 1.69
The Rb tumor suppressor is required for stress erythropoiesis. EMBO J (2004) 1.68
Selective killing of K-ras mutant cancer cells by small molecule inducers of oxidative stress. Proc Natl Acad Sci U S A (2011) 1.68
The comparative pathology of genetically engineered mouse models for neuroendocrine carcinomas of the lung. J Thorac Oncol (2015) 1.68
Optimality in the development of intestinal crypts. Cell (2012) 1.67
A reversible gene-targeting strategy identifies synthetic lethal interactions between MK2 and p53 in the DNA damage response in vivo. Cell Rep (2013) 1.67
Mapping a complete neural population in the retina. J Neurosci (2012) 1.64
Dynamic regulation of the Ras pathway via proteolysis of the NF1 tumor suppressor. Genes Dev (2003) 1.64